Skip to main content

Advertisement

Peer Review reports

From: Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan

Original Submission
27 Sep 2011 Submitted Original manuscript
29 Sep 2011 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 2
29 Sep 2011 Submitted Manuscript version 2
28 Oct 2011 Reviewed Reviewer Report - Samantha Hollingworth
6 Nov 2011 Reviewed Reviewer Report - Anna Kemp
22 Dec 2011 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 3
22 Dec 2011 Submitted Manuscript version 3
24 Dec 2011 Reviewed Reviewer Report - Samantha Hollingworth
6 Jan 2012 Reviewed Reviewer Report - Anna Kemp
28 Feb 2012 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 4
28 Feb 2012 Submitted Manuscript version 4
28 Feb 2012 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 5
28 Feb 2012 Submitted Manuscript version 5
28 Feb 2012 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 6
28 Feb 2012 Submitted Manuscript version 6
28 Feb 2012 Reviewed Reviewer Report - Anna Kemp
29 Feb 2012 Reviewed Reviewer Report - Samantha Hollingworth
13 Mar 2012 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 7
13 Mar 2012 Submitted Manuscript version 7
20 Mar 2012 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 8
20 Mar 2012 Submitted Manuscript version 8
21 Mar 2012 Author responded Author comments - Shiou-Huei Huang
Resubmission - Version 9
21 Mar 2012 Submitted Manuscript version 9
Publishing
20 Apr 2012 Editorially accepted
20 Apr 2012 Article published 10.1186/1471-2458-12-288

You can find further information about peer review here.

Back to article page